subject area of
- <p>Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study</p> Journal Articles
- Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease Journal Articles
- Emerging therapeutic options for the treatment of patients with symptomatic asthma Journal Articles
- Exploring the role of nerves in asthma; insights from the study of cough Journal Articles
- Survival with Tiotropium Compared to Long-Acting Beta-2-Agonists in Chronic Obstructive Pulmonary Disease Journal Articles
- The Canadian Optimal Therapy of COPD Trial: Design, Organization and Patient Recruitment Journal Articles
- The use of inhaled anticholinergics in chronic obstructive pulmonary disease. Is there cause for concern of cardiovascular safety? Journal Articles
- Tiotropium and chronic obstructive pulmonary disease Journal Articles
- Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives Journal Articles
- Tiotropium for the treatment of asthma: a drug safety evaluation Journal Articles
- Tiotropium in Combination with Placebo, Salmeterol, or Fluticasone–Salmeterol for Treatment of Chronic Obstructive Pulmonary Disease Journal Articles